TX HB 3318
died on adjournmentRelating to access to individualized investigational treatments for patients with life-threatening or severely debilitating illnesses.
Texas · 89th Legislature (2025 Regular Session) · lower
Quick answers
Did TX HB 3318 pass?
No. TX HB 3318 died when the 89th Legislature (2025 Regular Session) adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2025-04-21): Left pending in committee
What is TX HB 3318 about?
TX HB 3318 is a bill in the 89th Legislature (2025 Regular Session) titled “Relating to access to individualized investigational treatments for patients with life-threatening or severely debilitating illnesses.”.
Who sponsors TX HB 3318?
King, Lalani are the primary sponsors of TX HB 3318, joined by 1 cosponsor.
- Introduced
- 2025-03-21
- Latest action
- 2025-04-21 — Left pending in committee
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Kingprimary
- Lalaniprimary
- Plesacosponsor
Committees
Not provided by source.
Action timeline
2025-02-25
Filed
filing
2025-03-21
Read first time
introduction,reading-1
2025-03-21
Referred to Public Health
referral-committee
2025-04-17
Posting rule suspended
2025-04-21
Considered in public hearing
2025-04-21
Testimony taken/registration(s) recorded in committee
2025-04-21
Left pending in committee
Versions
Documents
Votes
Not provided by source.
Related bills
- Companion bill: SB 984
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:33:51.767464Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=TX&identifier=HB 3318. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.